As a healthcare professional, you work hard to offer the best possible care for patients. We work hard to develop novel and cutting-edge therapy for patients in need. We are committed to offering quality treatment, but this can only be achieved by partnering with a worldwide team of qualified investigators. By partnering with Retrotope, you have the backing of world-class talent and collaboration. Together we transform cutting-edge science into safe and accessible treatment for patients.
Retrotope is currently sponsoring a double-blind, placebo-controlled study in Friedreich’s Ataxia, an open-label study in Infantile Neuroaxonal Dystrophy (INAD), a Natural History study in INAD, as well as an extensive expanded access program.